CIK 0001551152 · Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320375147
- Phone
- (847) 932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,925,738
- in 1 filing
Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-31 | Quaggin Susan E Director | Grant or award · Stock Equivalent Units | +71 | $209.52 | $15K | 476 |
| 2025-03-31 | GONZALEZ RICHARD A Director | Gift | −2,450 | 386,479 | ||
| 2025-03-31 | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Option exercise | +25,700 | $79.02 | $2.0M | 112,066 |
| 2025-03-31 | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Sale | −25,700 | $209.49 | $5.4M | 86,366 |
| 2025-03-31 | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Sale | −33,132 | $210.54 | $7.0M | 53,234 |
| 2025-03-31 | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Option exercise · Option (Right to Buy) | −25,700 | $79.02 | $2.0M | 0 |
| 2025-03-14 | Reents Scott T EVP, CHIEF FINANCIAL OFFICER | Sale | −17,644 | $212.34 | $3.7M | 11,577 |
| 2025-03-03 | RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER | Sale 10b5-1 | −5,677 | $209.80 | $1.2M | 21,703 |
| 2025-03-03 | RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER | Sale 10b5-1 | −14,973 | $210.66 | $3.2M | 6,730 |
| 2025-03-03 | RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER | Sale 10b5-1 | −600 | $211.32 | $127K | 6,130 |
| 2025-03-03 | GONZALEZ RICHARD A Director | Sale | −6,168 | $210.53 | $1.3M | 388,929 |
| 2025-03-03 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise 10b5-1 | +2,918 | $144.54 | $422K | 7,537 |
| 2025-03-03 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise 10b5-1 | +7,315 | $149.62 | $1.1M | 14,852 |
| 2025-03-03 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise 10b5-1 | +7,775 | $175.28 | $1.4M | 22,627 |
| 2025-03-03 | Siatis Perry C EVP, GC AND SECRETARY | Sale 10b5-1 | −18,008 | $210.00 | $3.8M | 4,619 |
| 2025-03-03 | Siatis Perry C EVP, GC AND SECRETARY | Returned to the company · Option (Right to buy) 10b5-1 | −2,918 | $144.54 | $422K | 0 |
| 2025-03-03 | Siatis Perry C EVP, GC AND SECRETARY | Returned to the company · Option (Right to buy) 10b5-1 | −7,315 | $149.62 | $1.1M | 7,314 |
| 2025-03-03 | Siatis Perry C EVP, GC AND SECRETARY | Returned to the company · Option (Right to buy) 10b5-1 | −7,775 | $175.28 | $1.4M | 15,549 |
| 2025-02-28 | Thakkar Roopal EVP, R&D and CSO | Shares withheld for taxes | −4,678 | $205.02 | $959K | 42,276 |
| 2025-02-28 | Buckbee Kevin K SVP, CONTROLLER | Shares withheld for taxes | −3,699 | $205.02 | $758K | 7,797 |
Page 7 of 12 · 231 trades